Trial Profile
A Study to Evaluate the Efficacy of Combination Antiviral Therapy with and without Telaprevir in Patients with Recurrent Hepatitis C who Underwent Orthotopic Liver Transplant (OLT)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Aug 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Interferons; Mycophenolic acid; Ribavirin; Tacrolimus
- Indications Hepatitis C
- Focus Therapeutic Use
- 20 Aug 2015 New trial record